Erik B. Oleson

2.8k total citations
43 papers, 2.1k citations indexed

About

Erik B. Oleson is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Erik B. Oleson has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cellular and Molecular Neuroscience, 14 papers in Pharmacology and 13 papers in Cognitive Neuroscience. Recurrent topics in Erik B. Oleson's work include Neurotransmitter Receptor Influence on Behavior (36 papers), Neuroscience and Neuropharmacology Research (25 papers) and Cannabis and Cannabinoid Research (13 papers). Erik B. Oleson is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (36 papers), Neuroscience and Neuropharmacology Research (25 papers) and Cannabis and Cannabinoid Research (13 papers). Erik B. Oleson collaborates with scholars based in United States, Germany and New Zealand. Erik B. Oleson's co-authors include Joseph F. Cheer, David C. S. Roberts, Ronny N. Gentry, Vivian C. Chioma, Sara R. Jones, Rodrigo A. España, Peter W. Kalivas, Karen K. Szumlinski, Kevin D. Lominac and Paul Worley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Journal of Neuroscience.

In The Last Decade

Erik B. Oleson

41 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik B. Oleson United States 23 1.5k 764 687 429 244 43 2.1k
M. Scott Bowers United States 25 1.9k 1.2× 869 1.1× 1.2k 1.7× 186 0.4× 368 1.5× 42 2.9k
Eric J. Nunes United States 22 1.0k 0.7× 443 0.6× 452 0.7× 284 0.7× 104 0.4× 39 1.7k
M. Victoria Puig Spain 22 2.1k 1.4× 1.2k 1.5× 870 1.3× 387 0.9× 119 0.5× 32 3.2k
Zhi‐Bing You United States 24 1.7k 1.1× 521 0.7× 951 1.4× 223 0.5× 355 1.5× 45 2.6k
Cassandra D. Gipson United States 27 2.0k 1.3× 653 0.9× 957 1.4× 245 0.6× 137 0.6× 84 2.8k
Susana Mingote United States 26 1.7k 1.1× 935 1.2× 752 1.1× 121 0.3× 226 0.9× 33 2.6k
Ping Wu China 27 1.6k 1.0× 981 1.3× 665 1.0× 191 0.4× 76 0.3× 61 2.3k
Daina Economidou Italy 29 2.5k 1.6× 1.0k 1.3× 1.0k 1.5× 325 0.8× 376 1.5× 34 3.2k
Yann Pelloux France 23 1.7k 1.1× 819 1.1× 573 0.8× 133 0.3× 138 0.6× 40 2.3k
Robert H. Ring United States 24 870 0.6× 766 1.0× 653 1.0× 355 0.8× 323 1.3× 35 2.7k

Countries citing papers authored by Erik B. Oleson

Since Specialization
Citations

This map shows the geographic impact of Erik B. Oleson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik B. Oleson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik B. Oleson more than expected).

Fields of papers citing papers by Erik B. Oleson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik B. Oleson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik B. Oleson. The network helps show where Erik B. Oleson may publish in the future.

Co-authorship network of co-authors of Erik B. Oleson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik B. Oleson. A scholar is included among the top collaborators of Erik B. Oleson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik B. Oleson. Erik B. Oleson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Rebecca, et al.. (2025). High ovarian hormones present during fear extinction reduce fear relapse through a nigrostriatal dopamine pathway. Biology of Sex Differences. 16(1). 38–38.
2.
Oleson, Erik B., et al.. (2021). Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention. Frontiers in Synaptic Neuroscience. 13. 660218–660218. 12 indexed citations
3.
Gomez, Devan M., et al.. (2020). Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 104. 110031–110031. 17 indexed citations
4.
Gomez, Devan M., et al.. (2020). Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212–2 and heroin in adult male rats. Neuropharmacology. 182. 108374–108374. 13 indexed citations
5.
Wenzel, Jennifer M., Erik B. Oleson, Anthony B. Cole, et al.. (2018). Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain. Current Biology. 28(9). 1392–1404.e5. 69 indexed citations
7.
Oleson, Erik B., et al.. (2018). A Transient Dopamine Signal Represents Avoidance Value and Causally Influences the Demand to Avoid. eNeuro. 5(2). ENEURO.0058–18.2018. 19 indexed citations
8.
Rakowski, Dylan R., et al.. (2017). A transient dopamine signal encodes subjective value and causally influences demand in an economic context. Proceedings of the National Academy of Sciences. 114(52). E11303–E11312. 32 indexed citations
9.
Brodnik, Zachary D., et al.. (2017). Diazepam Concurrently Increases the Frequency and Decreases the Amplitude of Transient Dopamine Release Events in the Nucleus Accumbens. Journal of Pharmacology and Experimental Therapeutics. 364(1). 145–155. 26 indexed citations
10.
Wenzel, Jennifer M., et al.. (2014). A Role for Phasic Dopamine Release within the Nucleus Accumbens in Encoding Aversion: A Review of the Neurochemical Literature. ACS Chemical Neuroscience. 6(1). 16–26. 100 indexed citations
11.
Oleson, Erik B., et al.. (2013). Tales from the dark side: Do neuromodulators of drug withdrawal require changes in endocannabinoid tone?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 52. 17–23. 5 indexed citations
12.
Wang, Bin, et al.. (2013). Conditioned Contribution of Peripheral Cocaine Actions to Cocaine Reward and Cocaine-Seeking. Neuropsychopharmacology. 38(9). 1763–1769. 17 indexed citations
13.
Oleson, Erik B., et al.. (2012). Using dopamine research to generate rational cannabinoid drug policy. Drug Testing and Analysis. 5(1). 22–26. 12 indexed citations
14.
Oleson, Erik B., Michael Beckert, Carien S. Lansink, et al.. (2012). Endocannabinoids Shape Accumbal Encoding of Cue-Motivated Behavior via CB1 Receptor Activation in the Ventral Tegmentum. Neuron. 73(2). 360–373. 127 indexed citations
16.
Oleson, Erik B., Steven R. Childers, James E. Smith, et al.. (2008). Dopamine Uptake Changes Associated with Cocaine Self-Administration. Neuropsychopharmacology. 34(5). 1174–1184. 38 indexed citations
17.
Oleson, Erik B. & David C. S. Roberts. (2008). Behavioral Economic Assessment of Price and Cocaine Consumption Following Self-Administration Histories that Produce Escalation of Either Final Ratios or Intake. Neuropsychopharmacology. 34(3). 796–804. 79 indexed citations
18.
Budygin, Evgeny A., Erik B. Oleson, Tiffany A. Mathews, et al.. (2007). Effects of chronic alcohol exposure on dopamine uptake in rat nucleus accumbens and caudate putamen. Psychopharmacology. 193(4). 495–501. 76 indexed citations
19.
Szumlinski, Karen K., Kevin D. Lominac, Erik B. Oleson, et al.. (2005). Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain & Behavior. 4(5). 273–288. 151 indexed citations
20.
Szumlinski, Karen K., Kevin D. Lominac, Erik B. Oleson, et al.. (2005). Homer2 Is Necessary for EtOH-Induced Neuroplasticity. Journal of Neuroscience. 25(30). 7054–7061. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026